Jun 17, 202640 min
Matthew "Oki" O'Connor is the CEO of Scientific Affairs at Cyclarity Therapeutics, a clinical-stage biotech building a new class of medicines designed not to slow the accumulation of vascular damage but to reverse it...
About this Podcast:
On Translating Aging, we talk with the worldwide community of researchers, entrepreneurs, and investors who are moving longevity science from the lab to the clinic. We bring you a commanding view of the entire field, in the words of the people and companies who are moving it forward today. The podcast is sponsored by BioAge labs, a clinical-stage biotechnology company developing therapies to extend human healthspan by targeting the molecular causes of aging.
Pitch Analysis
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Public web form
Booking probability
31%
Guest openness
Selective
80/100
Required Score
Sign up to generate a grounded pitch for Translating Aging.
Signup to Generate a PitchQuestions about Translating Aging
What is Translating Aging about?
On Translating Aging, we talk with the worldwide community of researchers, entrepreneurs, and investors who are moving longevity science from the lab to the clinic. We bring you a commanding view of the entire field, in the words of the people and companies who are moving it forward today.
What has Translating Aging covered recently?
Recent episodes include "A Promise Kept, Phase 1 Data for a 7-KC-Clearing Drug (Oki O'Connor, Cyclarity Tx)" (17 June 2026, 40 minutes), "Beyond senolytics: senoadaptive drugs & clinical data on GPX4 modulation (Dr. Marco Quarta, Rubedo)" (20 May 2026, 47 minutes), and "Investing in the Future of Longevity (Sergey Jakimov, Managing Partner, LongeVC)" (13 August 2025, 51 minutes).
How often does Translating Aging publish?
Translating Aging publishes roughly monthly, with episodes averaging 42 minutes across 63 episodes.
How hard is it to get booked on Translating Aging?
Booking probability for Translating Aging is 31%, and the host is rated Selective on guests. Translating Aging requires a Pod Score of 80 or higher. Translating Aging's contact route on record: public web form.
Who should pitch Translating Aging?
The strongest fits for Translating Aging are Scientific Research & Development. Translating Aging has a science audience.
About the host
Translating Aging is a science podcast with 63 episodes published.
Host email not verified for this podcastSign in to unlock →
Recent episodes
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #61
Beyond senolytics: senoadaptive drugs & clinical data on GPX4 modulation (Dr. Marco Quarta, Rubedo)
May 20, 202647 minMarco Quarta is co-founder and Chief Scientific Officer of Rubedo Life Sciences, a precision-therapeutics company developing medicines that target the pathological cell states that drive age-associated disease. Marco's...
- Aug 13, 202551 min
Sergey Jakimov is the Managing Partner and co-founder of LongeVC, one of Europe's most active longevity-focused venture capital firms, currently raising its second fund targeting $250 million. In this episode, Chris and...
- Jul 9, 202548 min
In this special episode, host Chris Patil (VP-Media, BioAge) moderates a live panel discussion at the 25th Bay Area Aging Meeting at UCSF, bringing together six leading voices across the aging research ecosystem to...
- Jun 4, 202538 min
Michael Ringel is the Chief Operating Officer of Life Biosciences, a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging. Michael became COO of Life just a...
View More
- Apr 2, 202537 min
Dr. Janine Sengstack is the Chief Scientific Officer and co-founder of Junevity, a company created in 2023 with the mission of extending health span and lifespan through what they term "Cell Reset therapeutics." The...
- Jan 9, 202540 min
Dr. Andrew Brack, Program Manager at the Advanced Research Projects Agency for Health (ARPA-H), discusses PROSPR (Proactive Solutions for Prolonging Resilience), an ambitious new program aimed at extending human...
- Nov 20, 202427 min
Markus Gstöttner is the CEO of Clock.bio, a company devoted to extending and improving the quality of life by reversing the harmful effects of time in our cells. In this episode, Gstöttner shares how his company is...
Episode #54
Eliminating Pathogenic Cells to Treat Disease (Adam Freund & Remi Laberge, Arda Therapeutics)
Oct 30, 202446 minAdam Freund (CEO) and Remi Laberge (CTO) are the founders of Arda Therapeutics, a biotechnology company developing novel therapies that selectively eliminate harmful cell populations driving chronic diseases. In this...
Episode #53
Precision Epigenetic Medicines to Extend Healthspan (Alex Aravanis, Moonwalk Biosciences)
Oct 9, 202442 minAlex Aravanis is the CEO and co-founder of Moonwalk Biosciences, a biotechnology company pioneering precision epigenetic medicines. In this episode, Chris and Alex discuss Moonwalk's innovative approach to developing a...
- Jul 17, 202443 min
In this episode, Chris Patil speaks with Dr. Mehmood Khan, CEO of Hevolution Foundation, about the organization's mission to extend healthy human lifespan and better understand the aging process. Dr. Khan discusses...
Episode #51
Harnessing the Secretome to Combat Age-Related Immune Dysfunction (Dr. Hans Keirstead, Immunis)
May 8, 202448 minHans Keirstead, PhD, is the Chairman of the Board at Immunis, a biotechnology company researching and developing immune secretome products to address age-driven immune deficits. In this episode, Chris and Hans discuss...
- Apr 3, 202437 min
Dr. Daisy Robinton, co-founder and CEO of Oviva Therapeutics, discusses the company's innovative approach to improving women's healthspan by targeting the biology of ovarian aging. Motivated by her personal experiences...
- Mar 20, 202435 min
Dr. Noah Davidsohn, co-founder and CSO of Rejuvenate Bio, discusses the company's innovative work using gene therapies to treat age-related diseases in dogs and humans. In his conversation with host Chris Patil, he...
- Dec 6, 202344 min
30 Years of Aging Biology: A Pioneer’s Perspective (Cynthia Kenyon - VP Aging Biology, Calico Labs) Dr. Cynthia Kenyon reflects on the evolution of the longevity field over the 30 years since the publication of her...
- Nov 29, 202355 min
Dr. Jamie Justice is Executive Director of the newly launched XPRIZE Healthspan, a $101 M international competition to accelerate therapeutics targeting aging biology. In conversation with host Chris Patil, Dr. Justice...
- Nov 1, 202337 min
Dr. Coleen Murphy is a prominent aging researcher and author of the upcoming book “How We Age: The Science of Longevity” from Princeton University Press. In this wide-ranging discussion, Coleen provides insights into...
- Oct 11, 202342 min
Dr. Nicholas Hertz is the co-founder and former CSO of Mitokinin, a biotech company developing therapies targeting damaged mitochondria in neurodegenerative disease. Mitokinin was recently acquired by pharmaceutical...
- Sep 27, 202341 min
Dr. Alex Colville is the co-founder and General Partner of Age1 Ventures, a recently launched VC firm focused on funding contrarian, founder-led biotech companies aiming to extend healthy human lifespan. In this...
Episode #43
Reversing Skin Aging at the Cellular Level (Carolina Reis Oliveira and Alessandra Zonari, OneSkin)
Aug 23, 202336 minDr. Carolina Reis Oliveira and Dr. Alessandra Zonari are the co-founders of OneSkin, a company developing science-backed skincare products to reverse skin aging at the cellular level. In this episode, Carolina and...
Recent guests
Recent guests on Translating Aging. Study who booked and why before you pitch.
S
Sergey Jakimov
Founding and Managing Partner, Longenesis
D
Dr Nir Barzilai
Director of the Institute for Aging Research at the Albert Einstein College of Medicine, Institute for Longevity Research at Einstein
M
Michael Ringel
CPA, Chartered Special Needs Consultant, Special Needs Wealth Planning
A
Alex Colville
Co-Founder and General Partner, Australian Strategic Policy Institute
Best industries to pitch Translating Aging for
PitchCentric classifies Translating Aging under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Similar Podcasts
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Podcasts like Translating Aging
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ